Abiraterone Acetate Tablet
Product Images NDC 0904-6948

5 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 0904-6948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Label (49809a29 6558 43a3 A347 5027de44aa41 00)

Carton Label (49809a29 6558 43a3 A347 5027de44aa41 00)
Label for Abiraterone Acetate Tablets USP 250 mg oral tablets by Major Pharmaceuticals. The label includes the product name, strength, warning for pregnant women, Rx only indication, and a 30 tablet count. It provides dosing instructions, storage conditions, manufacturer and distributor details, and barcode with NDC 0904-6948-04.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A survival curve graph comparing the percentage of subjects without death over time (in months) between two groups: Abiraterone acetate and placebo. The x-axis represents months from randomization, and the y-axis represents percent of subjects without death. Data points for both groups are shown along the curves.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A Kaplan-Meier survival curve chart depicting the percentage of subjects without radiographic progression or death over 18 months from randomization. The graph compares two groups: one treated with Abiraterone acetate and the other with a placebo. Time in months is shown on the x-axis, and percent of subjects without progression or death is on the y-axis. The chart includes the number of patients at risk for each group at different time points.*
FDA Label Image

Figure 1 (Graph 1)

Figure 1 (Graph 1)
A Kaplan-Meier survival curve graph showing percent survival over time in months, comparing Abiraterone Acetate treatment with placebo. The x-axis represents time to death in months (0 to 21), and the y-axis shows percent survival (0 to 100%). Two lines represent survival rates for placebo and Abiraterone Acetate groups, with the number of patients at risk listed below the x-axis at selected time points.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Abiraterone Acetate showing its molecular configuration including rings and functional groups typical of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.